Literature DB >> 8815160

Neuropathological evaluation and apolipoprotein E gene polymorphism analysis in diffuse Lewy body disease.

C Kawanishi1, K Suzuki, T Odawara, E Iseki, H Onishi, T Miyakawa, Y Yamada, K Kosaka, N Kondo, T Yamamoto.   

Abstract

We performed a quantitative neuropathological investigation of senile plaques and neurofibrillary tangles in the brains of 14 Japanese patients with diffuse Lewy body disease (DLBD), and examined apolipoprotein E (APOE) gene polymorphism in these patients. Most DLBD brains had as many senile plaques as those with Alzheimer-type dementia (ATD), but fewer neurofibrillary tangles. The APOE epsilon 4 allele frequency in DLBD was 39.3%, similar to that previously reported in pathologically diagnosed ATD. DLBD and ATD are clinically and pathologically distinct, but may have common mechanisms with regard to the formation of amyloid deposition based on these findings. Future investigation of the pure form of DLBD may clarify the association between Lewy body dementia and APOE.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8815160     DOI: 10.1016/0022-510x(95)00312-p

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

1.  Sequence variants in eukaryotic translation initiation factor 4-gamma (eIF4G1) are associated with Lewy body dementia.

Authors:  Shinsuke Fujioka; Christina Sundal; Audrey J Strongosky; Monica Case Castanedes; Rosa Rademakers; Owen A Ross; Carles Vilariño-Güell; Matthew J Farrer; Zbigniew K Wszolek; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2012-11-04       Impact factor: 17.088

2.  Apolipoprotein E4 frequencies in a Japanese population with Alzheimer's disease and dementia with Lewy bodies.

Authors:  Seiju Kobayashi; Masaru Tateno; Tae Woo Park; Kumiko Utsumi; Hitoshi Sohma; Yoichi M Ito; Yasuo Kokai; Toshikazu Saito
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.